I also hope Sinopharm get approved by NPRA...my Kanger and Kstar shares can get unloaded..but it is just talk so far. Dah 7 months already since Dec 2020.
Noobie123 Bingo....If Sinopharm was truly just registered with NPRA. The big question is "IF" which means don't know, unsure, not confirmed. ---------------- Betul tu. Saya bukan insider atau agen kepada insider pun. Semua berdasarkan cerita / report yang diperoleh dari web.
Awak tengok, saya berhati-hati dalam laporan saya. Seboleh-bolehnya laporkan berita berdasarkan report sebenar.
Tak ada siapa pun saya point senapang untuk tembak untuk membaca dan percaya idea ini. Tapi adat nak share, itu saja.
Noobie123 I also hope Sinopharm get approved by NPRA ---------------- Betul. Saya pun dalam situasi sama. Hanya harapan saja yang dapat dikongsi.
Untuk saya, saya terlekat dalam satu saham saya cuba ambil langkah yang saya kira positif untuk membantu kaunter tersebut supaya ada harapan untuk naik kembali. Hanya usaha, kejayaan ditentukan oleh minat pelabur-pelabur di pasaran dan juga operator, kalau ada.
Berbeza, ada sesetengah orang yang lain, bila terlekat sesuatu kaunter saham, frust dan ambil jalan kutuk kaunter tersebut. Mungkin cara tersebut juga sesuai dengan matlamat mereka, termasuk untuk turunkan harga bagi beli balik pada harga rendah untuk average down saham mereka.
MZM2511, Jangan risau. I not saying you are a promoter. I can see you write on past reports, though got mistakes I point out like not Sole Distributor or not Main Contractor. And you admit the mistake. No problems.
I am just hoping Kanger Management will read all these frustrations and their performance so far is not trusting. They have to improve if they want investor confidence.
Kanger cannot keep issuing statements on this or that, hoping share prices would go up then they disappear. No follow up. They cannot simply say Sinopharm is expected to be delivered in May, approval by NPRA is in process but no concrete announcements. Talk is cheap for them but for some bilis investors, it is hard earned, sweat money.
Hehehe... Rights Issues 0.060... + 2.8 billion new shares .... share sedia ada dah 2.7 billion... lepas abis right issue total shares 5.6 billion... mmg kalah la LAMBO dan XOX dan AT.....mmg kene dump la sampai 0.030.. lowest boleh kena dump sampai 0.0050 pastu consolidate.. n dump lagi... lebih balik stay away ....
Also, the specific plan maybe faced certain changes in the conditions which caused the plan needed to be revised. --------------
On this possibility.....
1. The report was made on 9 March 2021 said that Kanger International Bhd will receive 10,000 doses of a Covid-19 vaccine for trial purposes.
2. The Sinopharm Covid-19 vaccine completed its 3rd Trial and approved by WHO on 7 May 2021.
3. Therefore, if Kanger want to bring the vaccine in May to Malaysia for trial purposes, the plan is not valid anymore because the vaccine has been finished its 3rd Trial.
4. The first plan to bring vaccine for trial purposes terminated, and the plan would be revised to, registering the vaccine with NPRA as it is the WHO approved vaccine.
it is very simple...got Sinopharm or no Sinopharm imported into Malaysia. Very simple yes or no. Kalau takde, say takde. If need funds and need to raise RI, say company no more money. Need to raise funds.Habis cerita. All other stories, MOUs, Press release, possibilities is not important anymore.
The RI issue is not related to vaccine distributorship proposal.
Its related to other expansion plans which is probably included:
1. The newly construction services business. 2. The proposed plan to acquire property for investment. 3. The proposed plan to acquire a company which involved in a construction material trading.
Today seems 72mil shares dumped to support 0.06. Support volumes which seem to be very strong past days now exhausted, salvaged by ringing bell at 5 pm, otherwise it could open a new trading range of 0.055-0.06.
some u say i like sun light so much, i dun care is hot as long as is bright, but did u see the shadow behind?? when ever got light it come shadow... trade at bursa, u had to know good is not only come from fry up, also when u buy low.. happy trade at bursa jungle... u eat ppl or ppl eat u..
Speaking at a press conference after visiting a vaccination centre in Penang on Thursday (Jun 3), Mr Khairy said states and private hospitals in Malaysia can source their own vaccines as long as these vaccines have been approved by the World Health Organization (WHO).
“If the state governments want to purchase their own vaccines and bring these other vaccines in, they can go ahead. We can even facilitate discussions with the pharmaceutical companies," said Mr Khairy.
The state governments or private hospitals need only register these purchases with the Health Ministry's National Pharmaceutical Regulatory Agency (NPRA), he added.
1. Until 21 May 2021, the Sinopharm Covid-19 vaccine was not registered with NPRA yet.
As per report on 21 May 2021: "The government is open to any party that has the capability and clinical data of the Sinopharm Covid-19 vaccine to register it with the National Pharmaceutical Regulatory Agency (NPRA)", says Khairy Jamaluddin.
2. The earliest registering date with NPRA can posibly be done after 21 May 2021.
3. Reports by Kanger official on 27 May 2021 stated that Kanger has started the process of registering the Sinopharm vaccine with NPRA.
As per report: “the process of registering the Sinopharm vaccine (with NPRA) has started and we hope to receive some good news on its approval soon.”
Khairy also mentioned that Covid-19 vaccines will enter the private market by August. He said that private vaccination will help the government ramp up the national Covid-19 vaccination programme, as those who are able to pay for the vaccines will be able to do so.
“I also anticipate by about August, we will have a private vaccine market. So right now, it’s difficult for private because vaccines are in short supply. But by August, I think that there will be some companies who will be approved to bring in some private vaccines from China. I know Sinopharm and all that are going to be registered here,” Khairy added.
“That’s also part of the plan. I’ve been talking to the Ministry of Health to ensure that the private market by August can take off to help us.”
1. Kanger planned to bring Sinopharm Covid-19 vaccine for trial purposes. The report was made on 9 March 2021 said that Kanger International Bhd will receive 10,000 doses of a Covid-19 vaccine for trial purposes in May 2021.
2. The Sinopharm Covid-19 vaccine completed its 3rd Trial and approved by WHO on 7 May 2021.
3. Therefore, if Kanger want to bring the vaccine in May to Malaysia for trial purposes, the plan is not valid anymore because the vaccine has been finished its 3rd Trial.
4. The first plan to bring vaccine for trial purposes terminated, and the plan would be revised to, registering the vaccine with NPRA as it is the WHO approved vaccine.
5. Until 21 May 2021, the Sinopharm Covid-19 vaccine was not registered with NPRA yet.
6. There will be a big probability that the report by Kanger official is true,that the company has started to register the said vaccine with NPRA, based on 27 May 2021 report.
Great, KJ mentioned sinopharm is going to be registered here! Private vaccination program jalan in August, just 5.5 weeks ahead! Hope to top up some more tomorrow!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Noobie123
1,661 posts
Posted by Noobie123 > 2021-06-22 09:57 | Report Abuse
I also hope Sinopharm get approved by NPRA...my Kanger and Kstar shares can get unloaded..but it is just talk so far. Dah 7 months already since Dec 2020.